United States: Recent Texas Prosecutions Reveal New Federal Enforcement Tools And Focus On Private Insurance

Last Updated: May 2 2019
Article by Adam H. Laughton

Three cases recently wrapped up in the Northern and Southern Districts of Texas reveal an increased focus on health care fraud committed against private commercial third-party payors, as well as the tools that the Department of Justice (DOJ) is using to prosecute these schemes.  Historically, many of the prosecutions in the health care industry have focused on waste, fraud and abuse in federal health care programs, such as Medicare and Medicaid.  However, these prosecutions show that US Attorneys and regulators have a renewed interest in prosecuting fraud even outside of those programs.  This should give providers and others pause when they consider arrangements that exclude Medicare or Medicaid claims or patients, and which have traditionally been thought of as safe or low-risk.

Forest Park Medical Center

Forest Park Medical Center (“FPMC”) was a physician-owned hospital in Dallas that opened in 2009.  In 2016, 21 individuals associated with FPMC or its business partners were indicted in the Northern District of Texas for various health care offenses, including conspiracy to violate the federal Anti-Kickback Statute.  However, the most novel part of the indictment was the charge of violation of the federal Travel Act (18 U.S.C. §1952), which punishes the use of various means of interstate commerce for the purposes of carrying on unlawful activity under another statute, here the Texas commercial bribery statute (Texas Penal Code §32.43).  The DOJ alleged that individuals associated with FPMC bribed physicians (either directly or indirectly) with cash payments and other incentives (gifts, discounted leases, etc.) to send patients with commercial insurance or certain federal programs to FPMC, and used cash to steer patients with lower-reimbursing federal programs, including Medicare and Medicaid, to other facilities.  FPMC was also engaged in routine waivers of patient responsibility amounts, such as copayments and deductibles.  FPMC and the conspirators engaged in extensive tracking of referrals and referral sources, and rewarded physicians accordingly.  On April 10, 2019, seven of the indicted defendants were found guilty by a federal jury.  Ten other defendants already pled guilty to charges.  Two other defendants were found not guilty or the jury deadlocked on charges against them.

Palo Pinto General Hospital

Palo Pinto General Hospital (“PPGH”) is a hospital owned and operated by a county hospital district.  In March 2019, the CEO of PPGH, Harris Brooks, agreed to plead guilty to several charges, chief among them conspiracy to commit healthcare fraud (18 USC §1347).  It was alleged that Mr. Brooks had conspired with others to defraud commercial third-party payors by submitting false claims for laboratory services.  In particular, PPGH was engaged in a fraudulent pass-through billing scheme, where laboratory services were performed by other laboratories, and other entities who were in contractual relationships with PPGH would market these services to physicians, but all claims and services were billed through PPGH, which had no relationships with the laboratories or the patients whose claims were billed.

Red Oak Hospital

In February 2019, a federal jury found two individuals, Harcharan Narang, M.D. and Dayakar Moparty, guilty of conspiracy to commit health care fraud.  A third indicted co-conspirator pled guilty before trial.  Dr. Narang and Mr. Moparty, who owned and managed Red Oak Hospital in Houston, were engaged in a scheme to submit claims for medical unnecessary diagnostic tests.  These tests were ordered routinely, without regard to medical necessity for that individual.  In addition, some services were billed but never performed.  In some cases, when one payor would not pay Red Oak for a test, the parties would submit the bill through other entities, none of which had treated or seen the patient.  The conspirators enriched themselves by paying distributions of these fraudulently obtained proceeds.

Key Takeaways

These three prosecutions reveal two particularly important facts for providers and others involved in the health care industry in Texas.  First, an arrangement which does not take Medicare or Medicaid is not per se safe or without risk.  Regulators are focusing on schemes and conspiracies that have the effect of driving up costs in the commercial healthcare industry.  One interesting side note is that Texas has a statute, the Texas Patient Solicitation Act (Tex. Occ. Code §102.001 et seq.), which is worded similarly to the federal Anti-Kickback Statute, but includes all payors.  However, historically, it has never been enforced on a state or federal level.  This statute did not come up in any of the above indictments, even though some of the accused had arguably violated it.  It remains to be seen whether regulators or state officials will take notice of this potential enforcement tool.

Second, the government is using new tools to prosecute health care fraud.  This is most apparent in the Forest Park Medical Center case, which introduced the use of the federal Travel Act.  Travel Act prosecutions depend on the use of interstate commerce to commit some other criminal act.  Thus, it depends on some other predicate offense, such as the Texas Patient Solicitation Act.  In the Forest Park case, it appears to have been use to federalize the prosecution of a Texas commercial bribery case, of which it would be the first of its kind.  Because the most significant parts of the conspiracy did not involve Medicare or Medicaid claims, the more frequently utilized Stark Law and Anti-Kickback Statute were presumably not available.


Providers and others involved in the healthcare industry in Texas should review their operations and arrangements and take precautions as necessary in light of these recent prosecutions.  In particular:

  • Watch out for sham arrangements– In the Forest Park case, there were written agreements governing payments made to referral sources.  The agreements purported to pay physicians for marketing services.  However, the government’s investigation determined that these arrangements were a sham, and that no legitimate marketing services were involved.  Rather, the payments were a quid pro quo for referrals.  When entering into any arrangement for services with any person, and in particular a referral source, make sure that the services described are bona fide, commercially reasonable, and actually performed.  The parties should be able to document the quantity and result of any services performed.  Be diligent about reviewing the outcomes and performance of any party with which your organization has a contract.  If the purpose of an arrangement is not to pay for referrals, you likely have no legitimate need to track referrals.
  • Do not assume you are safe in a “no federal program business” arrangement– For many years, health care industry participants have assumed that their arrangements were sound if they did not involve federal program reimbursement (particularly Medicare and Medicaid).  While it is true that the Stark Law and Anti-Kickback Statute would not apply in such circumstances, these recent cases reveal that the DOJ is taking an increased interest in fraud that only affects commercial third-party health plans.  Examine any existing arrangements that do not cover Medicare or Medicaid and determine if there is any fraudulent activity, or if the arrangement appears to be a sham or fraudulent.
  • Focus on medical necessity and patient consent– No service, under any type of health plan, should be performed without being medically necessary.  Medical necessity is a conclusion, but it is built on the back of evidence and observation.  Be sure that your medical records adequately document the physician’s support and reason for medical necessity, not just the conclusion.  In addition, any time a patient is referred to another provider or if bills or invoices will appear in the name of any other provider, patients should be notified in writing and in advance of this fact, and a signed acknowledgment of the patient’s receipt of that notice should be obtained and kept in the patient’s medical record.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions